Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor
Year: 2020
Type: article
Authors: James M. Apgar, Robert R. Wilkening, Dann L. Parker, Dongfang Meng, Kenneth J. Wildonger, Donald Sperbeck, Mark L. Greenlee, James M. Balkovec, Amy M. Flattery, George K. Abruzzo, Andrew M. Galgoci, Robert A. Giacobbe, Charles J. Gill, Ming-Jo Hsu, Paul Liberator, Andrew S. Misura, Mary Motyl, Jennifer Nielsen Kahn, Maryann Powles, Fred Racine, Jasminka Dragovic, Weiming Fan, Robin Kirwan, Shu Lee, Hao Liu, Ahmed Mamai, Kingsley Nelson, Michael Peel
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096840765